--- title: 'Morning Brief — Wednesday, October 21, 2026' type: 'episode' url: 'https://doc.social/episodes/morning-brief-2026-10-21' show: 'doc social Morning Brief' show_url: 'https://doc.social/podcasts/morning-brief' published: '2026-10-21' audio: 'https://media.doc.social/podcasts/morning-brief/2026-10-21.mp3' --- # Morning Brief — Wednesday, October 21, 2026 Intuitive's Q3: revenue up 22% to $3.05B on ~14% da Vinci procedure growth and 546 system placements, plus a $450M charge to settle the hospital antitrust class action over instrument service and repair · Synergy Spine's PERFORM real-world study at NASS 2026: 120 single-level Synergy Disc patients at five UK, EU and Australian sites, 30% with same-surgery ACDF, NDI 43.4 to 9.5 at one year, no… ## Summary 4 stories this morning, for surgeons and the people who support them. - **Intuitive's Q3: revenue up 22% to $3.05B on ~14% da Vinci procedure growth and 546 system placements, plus a $450M charge to settle the hospital antitrust class action over instrument service and repair** — October 20, 2026 earnings release (8-K Ex. 99.1): Q3 revenue $3.05B vs $2.51B; worldwide procedures ~15%, da Vinci ~14%, Ion ~31%; 546 da Vinci systems placed (315 da Vinci 5) vs 427 (240); installed base 12,094; 2026 da Vinci procedure growth guided ~14-15%, closer to the midpoint. In October, after mediation in In re: da Vinci Surgical Robot Antitrust Litigation, Intuitive agreed to pay $450M plus mutually agreed injunctive relief, without admitting liability, subject to preliminary and final court approval; injunctive terms not disclosed. The class action was brought by hospitals (Larkin Community Hospital; Franciscan Alliance and King County Public Hospital District No. 1) over service and repair of da Vinci instruments, per Intuitive's 10-K (https://www.sec.gov/Archives/edgar/data/1035267/000103526723000019/isrg-20221231.htm) and class counsel (https://www.cohenmilstein.com/case-study/re-da-vinci-surgical-robot-antitrust-litigation/); class certified March 2025. Second report: Citeline (https://medtech.citeline.com/MT125791/Rising-Procedure-Volumes-Push-Intuitive-Surgical-Third-Quarter-Earnings-Above-Forecast). [Source](https://www.sec.gov/Archives/edgar/data/0001035267/000103526726000067/q326ex-991earningsrelease.htm) - **Synergy Spine's PERFORM real-world study at NASS 2026: 120 single-level Synergy Disc patients at five UK, EU and Australian sites, 30% with same-surgery ACDF, NDI 43.4 to 9.5 at one year, no explants or device-related adverse events** — October 20, 2026 company release: ongoing open-label pragmatic study with prospective and retrospective cohorts; mean NDI 43.4 pre-op, 16.4 at six weeks, 9.5 at one year, 7.8 at two years, 10.8 at three years; neck pain 5.8 to 1.2 at one year; PRO data for 78% of eligible patients at one and two years and 63% at three; Kaplan-Meier device survival 100% with censoring at last visit; one adjacent-level disc replacement after an acute prolapse. U.S. PMA for one level C3-C7 came in February 2026; the U.S. IDE two-year result (87.1% composite success vs 56.6% for historical ACDF controls) was already covered 2026-09-17. Also reported by ORTHOWORLD (https://www.orthoworld.com/synergy-spine-shares-synergy-disc-multicenter-study-results/). Centinel's two-level prodisc C Nova approval was covered 2026-10-15. [Source](https://prnewswire.com/news-releases/synergy-spine-solutions-announces-perform-international-real-world-study-results-for-synergy-disc-at-north-american-spine-society-2026-annual-meeting-302913570.html) - **J Neurosurg Spine, RWTH Aachen: in 725 navigated screws in 121 patients, planned-versus-achieved trajectory divergence was largest in the subaxial cervical spine (4.2 degrees axial) and barely tracked misplacement; 95% of screws were acceptable** — Published online October 16, 2026 (PMID 42887028). Prospective analysis of posterior instrumented fusions 2021-2023 with intraoperative 3D navigation; Gertzbein-Robbins grading. Axial divergence: subaxial cervical 4.2 plus or minus 3.0 degrees vs atlantoaxial 2.6, thoracic 2.6, lumbar 2.9 (p<0.01); sagittal 4.1 subaxial cervical vs 2.8 thoracic (p<0.001). Correlation between trajectory deviation and misplacement weak or absent. Navigation platform not named in the abstract. [Source](https://doi.org/10.3171/2026.5.SPINE2699) - **J Arthroplasty, Rush: preoperative SSRI use tied to more two-year complications after primary THA (5.2% vs 3.2%) in 77,958 matched users, with no dose-response** — Published online October 16, 2026 (PMID 42887707). Claims database 2010-2023; patients without osteoporosis who filled an SSRI within 60 days before surgery, matched 1:3 to 233,277 SSRI-naive controls on age, sex, CCI and history of depression, anxiety, cognitive disorders and substance use. Adjusted odds: loosening 1.5, periprosthetic fracture 1.8, PJI 1.7, dislocation 2.0, revision 1.7 (all p<0.001). Low, medium and high doses showed no dose-dependent relationship; authors conclude SSRIs are unlikely to be directly responsible. [Source](https://doi.org/10.1016/j.arth.2026.10.008) ### Contribute to the Brief Faculty can send the show a note — a reaction to a paper, a correction, a read on a rule change — either written, which we shape for broadcast and read in the show's voice, or as a voice note under three minutes, which airs in your own voice. Send one from [Studio](https://next.doc.social/studio). Not on doc social yet? [Contribute a lecture or join the network](https://next.doc.social/contribute) — doc social is a clinical education platform for clinicians, and this show is one part of it. _Narration is synthesized. Reporting and editorial judgement are ours, and every story above links to its source._